Purple Biotech Ltd.PPBTNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year operating income growth rate
Latest
-11.12%
↓ 287% vs avg
Percentile
P33
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
5.94%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -11.12% |
| Q2 2025 | 12.09% |
| Q1 2025 | -38.39% |
| Q4 2024 | 52.37% |
| Q3 2024 | 38.32% |
| Q2 2024 | 22.57% |
| Q1 2024 | 28.74% |
| Q4 2023 | -9.05% |
| Q3 2023 | -11.92% |
| Q2 2023 | -0.25% |
| Q1 2023 | 22.41% |
| Q4 2022 | -29.92% |
| Q3 2022 | -241.53% |
| Q2 2022 | 148.97% |
| Q1 2022 | -64.70% |
| Q4 2021 | -46.32% |
| Q3 2021 | 16.01% |
| Q2 2021 | 44.54% |
| Q1 2021 | -130.10% |
| Q4 2020 | 624.95% |
| Q3 2020 | -92.14% |
| Q2 2020 | 0.00% |
| Q1 2020 | -64.01% |
| Q4 2019 | 26.98% |
| Q3 2019 | -0.84% |
| Q2 2019 | 0.00% |
| Q1 2019 | -3.07% |
| Q4 2018 | 0.00% |
| Q3 2018 | 34.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -4.05% |
| Q4 2017 | 0.00% |
| Q3 2017 | 17.07% |
| Q2 2017 | -20.40% |
| Q1 2017 | -25.25% |
| Q4 2016 | 0.00% |
| Q3 2016 | -27.42% |
| Q2 2016 | 0.00% |
| Q1 2016 | -26.42% |
| Q4 2015 | -4.69% |